Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $111.71 USD
Change Today +0.49 / 0.44%
Volume 12.1M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Xetra
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter B. Dervan Ph.D.

Former Member of the Scientific Advisory Board, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 2 different organizations across 4 different industries.

See Board Relationships
68--

Background*

Dr. Peter B. Dervan, Ph.D. served as Chairman, Division of Chemistry and Chemical Engineering at the California Institute of Technology until 1999. Dr. Dervan is a Founding Member of Gilead Sciences Inc., and which he joined it in August 1987. He serves as a Director of GeneSoft. He serves as a Member of the Scientific Advisory Board at GeneSoft and the Robert A. Welch Foundation. He served as a Member of the Scientific Advisory Board at Gilead Sciences Inc., since August ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

1997-2011
Former Director, Chairman of Nominating and Corporate Governance Committee, Chairman of Nominating and Corporate Governance Committee, Director, Member of Special Transition Committee, Member of Organization and Compensation Committee and Member of Organization and Compensation Committee
2014-Present
Trustee

Education*

Bachelor's Degree 1967
Boston College
PhD 1972
Yale University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $111.71 USD +0.49

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.